Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009

J Infect Dis. 2011 Mar 15;203(6):838-46. doi: 10.1093/infdis/jiq124.

Abstract

Background: Oseltamivir resistance among 2009 pandemic influenza A (H1N1) viruses (pH1N1) is rare. We investigated a cluster of oseltamivir-resistant pH1N1 infections in a hospital ward.

Methods: We reviewed patient records and infection control measures and interviewed health care personnel (HCP) and visitors. Oseltamivir-resistant pH1N1 infections were found with real-time reverse-transcription polymerase chain reaction and pyrosequencing for the H275Y neuraminidase (NA) mutation. We compared hemagglutinin (HA) sequences from clinical samples from the outbreak with those of other surveillance viruses.

Results: During the period 6-11 October 2009, 4 immunocompromised patients within a hematology-oncology ward exhibited symptoms of pH1N1 infection. The likely index patient became febrile 8 days after completing a course of oseltamivir; isolation was instituted 9 days after symptom onset. Three other case patients developed symptoms 1, 3, and 5 days after the index patient. Three case patients were located in adjacent rooms. HA and NA sequences from case patients were identical. Twelve HCP and 6 visitors reported influenza symptoms during the study period. No other pH1N1 isolates from the hospital or from throughout the state carried the H275Y mutation.

Conclusions: Geographic proximity, temporal clustering, presence of H275Y mutation, and viral sequence homology confirmed nosocomial transmission of oseltamivir-resistant pH1N1. Diagnostic vigilance and prompt isolation may prevent nosocomial transmission of influenza.

MeSH terms

  • Adult
  • Aged
  • Antiviral Agents / pharmacology*
  • Case-Control Studies
  • Cross Infection / epidemiology*
  • Cross Infection / virology
  • Disease Outbreaks
  • Drug Resistance, Viral
  • Hospitals
  • Humans
  • Immunocompromised Host*
  • Influenza A Virus, H1N1 Subtype / classification
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Influenza A Virus, H1N1 Subtype / genetics
  • Influenza, Human / drug therapy
  • Influenza, Human / epidemiology*
  • Interviews as Topic
  • Middle Aged
  • North Carolina / epidemiology
  • Oseltamivir / pharmacology*
  • Pandemics
  • Phylogeny
  • Retrospective Studies

Substances

  • Antiviral Agents
  • Oseltamivir